Pankaj Singh currently develops content for healthcaremotives.com and numerous other news portals. A Post Graduate in Management by qualification, he worked as an underwriter in the UK insurance domain before deciding to switch his profession. He can be contacted at- [email protected] | https://twitter.com/PankajSingh2605
The FT:X2000 has resolution of 2048×1536 and can operate at up to 2400 frames per second. Optalysys Ltd., a company renowned for its light-speed optical AI systems recently announced that FT:X 2000, the first optical co-processor system in the world, will now be available to order. Experts are of the …
Patients with severe depressive disorder are only considered for treatment with Spravato after they have undergone at least two antidepressant treatments. The Food and Drug Administration of the United States recently approved the Spravato nasal spray for the treatment of depression in adults in addition to oral antidepressants. It is …
Novo Nordisk, the Demark-based diabetes care giant, has recently published positive results for a 30 week trial to evaluate the safety and efficacy of Ozempic (semaglutide) 1.0mg in combination with SGLT-2 inhibitor (SGLT-2i) treatment. The SUSTAIN 9 Phase IIIb study was reportedly performed in adults having Type 2 diabetes, who …
Malgrat’s production lines are designed to handle the diverse scales needed, from pharmaceutical development phase to commercialization stage Japanese manufacturing firm AGC Inc., has recently announced that the company has completed the acquisition of Malgrat Pharma Chemicals (MPC), S.L.U, a Spain based synthetic pharmaceutical active ingredient producer. Apparently, the financial …
The firms will be using Abpro’s innovative DiversImmune technology for developing bispecific antibodies for immuno-oncology Abpro is reportedly teaming up with China-based NJCTTQ for developing new, innovative bispecific antibodies by deploying its antibody discovery platform. As part of the agreement, Abpro would receive up to $4 billion, which will be …
Leading diagnostics information services provider, Quest Diagnostics, and South Carolina’s Regional Medical Center (RMC) have announced a partnership aimed at enhancing the value and quality of diagnostic services for doctors and their patients. Under the new partnership agreement, Quest would be providing full laboratory management services. Steve Rusckowski, President, Chairman …
DuPont Nutrition & Health, through its agreement with Lonza, will be able to obtain a significant volume for the growing global HMOs market. Lonza Specialty Ingredients, biotechnology and specialty ingredient company and DuPont Nutrition & Health, the Specialty Products Division business of DowDuPont recently announced that they have entered into …
The shift that will occur due to elimination of hospital fees for imaging services is anticipated to reduce patient costs by nearly $7 million a year. UNC REX Healthcare, the private, not-for-profit health care system, recently announced that it has joined forces with Wake Radiology to expand specialized imaging services …
Dupixent showed significant improvement in patients with acute chronic rhinosinusitis with nasal polyps as well as co-morbid asthma. A recently released report for Phase 3 trials of Dupixent has conclusively demonstrated that dupilumab in combination with corticosteroid nasal spray has the potential to improve chronic sinus disease. Besides this, the …
The company would be licensing the rights to develop as well as commercialize TQJ230 for targeted cardiovascular therapy If approved, the TQJ230 would be a first in class therapy specifically designed for elevated Lp(a) Novartis International AG (Novartis), a renowned Swiss pharmaceutical firm, has reportedly announced that it has decided …
